Premium
Novel regulatory systems for acetylcholine release in rat striatum and anti‐Alzheimer's disease drugs
Author(s) -
Muramatsu Ikunobu,
Uwada Junsuke,
Yoshiki Hatsumi,
Sada Kiyonao,
Lee KungShing,
Yazawa Takashi,
Taniguchi Takanobu,
Nishio Matomo,
Ishibashi Takaharu,
Masuoka Takayoshi
Publication year - 2019
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/jnc.14701
Subject(s) - acetylcholine , muscarinic acetylcholine receptor , neurotransmitter , chemistry , muscarine , cholinergic , physostigmine , autoreceptor , galantamine , neurotransmission , nicotinic agonist , pharmacology , neuroscience , medicine , biology , biochemistry , receptor , antagonist , donepezil , dementia , disease
Regulation of neurotransmitter release in the central nervous system is complex. Here, we investigated regulatory mechanisms for acetylcholine (ACh) release from cholinergic neurons by performing superfusion experiments with rat striatal segments after labelling the cellular ACh pool with [ 3 H]choline. Electrical stimulation-evoked pronounced [ 3 H]ACh release from cholinergic neurons. The estimated quantity of [ 3 H]ACh release per pulse of electrical stimulation was reduced by an increase in stimulus frequency, showing an inverse correlation between release probability of ACh and neuronal excitation. ACh release was also negatively regulated by pre-synaptic muscarinic ACh receptors (mAChRs). The autoinhibition induced by released ACh was predominantly suppressed by the M 2 -selective antagonist AF-DX 116, partially inhibited by M 3 -selective darifenacin, and minimally by M 4 -selective PD 102807. Other subtype-selective antagonists had no effect at subtype-selective concentrations. ACh esterase (AChE) inhibitors (diisopropylfluorophosphate, donepezil and galantamine) at concentrations that mostly inhibit esterase activity reduced [ 3 H]ACh release, and the reduction was abolished by treatment with atropine. This implies that pre-synaptic autoreceptors are activated more after blockade of ACh hydrolysis, leading to autoinhibition of ACh release and consequent reduction in synaptic ACh concentrations. [ 3 H]efflux was also enhanced by ACh uptake inhibitors (100 μM hemicholinium-3 and physostigmine), regardless of ACh hydrolysis. This study shows that synaptic ACh concentrations in striatal cholinergic neurons are regulated in a complex manner by many factors such as release probability, pre-synaptic M 2 /M 3 /M 4 mAChRs, AChE and post-synaptic ACh uptake, and provides important information about cholinergic neurotransmission for future exploration of therapeutic strategies for Alzheimer's and other central nervous system diseases. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/openscience-badges/.